19 relations: American Academy of Child and Adolescent Psychiatry, Child and adolescent psychiatry, Editor-in-chief, Elsevier, GlaxoSmithKline, Healthy Skepticism, Impact factor, Journal Citation Reports, Leemon McHenry, Martin Keller (psychiatrist), Medical journal, MEDLINE, Paroxetine, Peer review, PubMed, Science Citation Index, Study 329, Thomson Reuters, Web of Science.
American Academy of Child and Adolescent Psychiatry
The American Academy of Child and Adolescent Psychiatry (AACAP) is a 501(c)(3) non-profit professional association in the United States dedicated to facilitating psychiatric care for children and adolescents.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and American Academy of Child and Adolescent Psychiatry · See more »
Child and adolescent psychiatry
Child and adolescent psychiatry or pediatric psychiatry is a branch of psychiatry that focuses on the diagnosis, treatment, and prevention of mental disorders in children, adolescents, and their families.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Child and adolescent psychiatry · See more »
Editor-in-chief
An editor-in-chief, also known as lead editor, chief editor, managing or executive editor, is a publication's editorial leader who has final responsibility for its operations and policies.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Editor-in-chief · See more »
Elsevier
Elsevier is an information and analytics company and one of the world's major providers of scientific, technical, and medical information.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Elsevier · See more »
GlaxoSmithKline
GlaxoSmithKline plc (GSK) is a British pharmaceutical company headquartered in Brentford, London.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and GlaxoSmithKline · See more »
Healthy Skepticism
Healthy Skepticism Inc is an international non-profit organisation whose main aim is to "improve health by reducing harm from misleading drug promotion".
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Healthy Skepticism · See more »
Impact factor
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Impact factor · See more »
Journal Citation Reports
Journal Citation Reports (JCR) is an annual publication by Clarivate Analytics (previously the intellectual property of Thomson Reuters).
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Journal Citation Reports · See more »
Leemon McHenry
Leemon McHenry is a bioethicist and a lecturer in philosophy at California State University, Northridge, in the United States.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Leemon McHenry · See more »
Martin Keller (psychiatrist)
Martin Keller is an American psychiatrist.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Martin Keller (psychiatrist) · See more »
Medical journal
A medical journal is a peer-reviewed scientific journal which communicates medical information to physicians and other health professionals.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Medical journal · See more »
MEDLINE
MEDLINE (Medical Literature Analysis and Retrieval System Online, or MEDLARS Online) is a bibliographic database of life sciences and biomedical information.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and MEDLINE · See more »
Paroxetine
Paroxetine, also known by trade names including Paxil and Seroxat among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used to treat major depressive disorder, obsessive-compulsive disorder, social anxiety disorder, panic disorder, posttraumatic stress disorder, generalized anxiety disorder and premenstrual dysphoric disorder. It has also been used in the treatment of hot flashes and night sweats associated with menopause. It has a similar tolerability profile to other SSRIs. The common side effects include drowsiness, dry mouth, loss of appetite, sweating, trouble sleeping and delayed ejaculation. It may also be associated with a slightly increased risk of birth defects. The rate of withdrawal symptoms in young people may be higher with paroxetine and venlafaxine than other SSRIs and SNRIs. Several studies have associated paroxetine with suicidal thinking and behavior in children and adolescents. Marketing of the drug began in 1992 by the pharmaceutical company SmithKline Beecham, known since 2000 as GlaxoSmithKline. Generic formulations have been available since 2003 when the patent expired. The United States Department of Justice fined GlaxoSmithKline $3 billion in 2012, including a sum for withholding data on paroxetine, unlawfully promoting it for under-18s and preparing an article, following one of its clinical trials, study 329, that misleadingly reported the drug was effective in treating adolescent depression.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Paroxetine · See more »
Peer review
Peer review is the evaluation of work by one or more people of similar competence to the producers of the work (peers).
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Peer review · See more »
PubMed
PubMed is a free search engine accessing primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and PubMed · See more »
Science Citation Index
The Science Citation Index (SCI) is a citation index originally produced by the Institute for Scientific Information (ISI) and created by Eugene Garfield.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Science Citation Index · See more »
Study 329
Study 329 was a clinical trial conducted in North America from 1994 to 1998 to study the efficacy of paroxetine, an SSRI anti-depressant, in treating 12- to 18-year-olds diagnosed with major depressive disorder.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Study 329 · See more »
Thomson Reuters
Thomson Reuters Corporation is a Canadian multinational mass media and information firm.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Thomson Reuters · See more »
Web of Science
Web of Science (previously known as Web of Knowledge) is an online subscription-based scientific citation indexing service originally produced by the Institute for Scientific Information (ISI), now maintained by Clarivate Analytics (previously the Intellectual Property and Science business of Thomson Reuters), that provides a comprehensive citation search.
New!!: Journal of the American Academy of Child and Adolescent Psychiatry and Web of Science · See more »
Redirects here:
J Am Acad Child Adolesc Psychiatry, J. Am. Acad. Child Adolesc. Psychiatry, J. Am. Acad.Child Adolesc. Psychiatry, JAACAP, Journal of the American Academy of Child & Adolescent Psychiatry.
References
[1] https://en.wikipedia.org/wiki/Journal_of_the_American_Academy_of_Child_and_Adolescent_Psychiatry